Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Global smoking cessation market • Global tobacco alternative gums market • Five forces analysis PART 06: Market segmentation by nicotine content • Global 2-mg nicotine gum market • Global 4-mg nicotine gum market PART 07: Market segmentation by distribution channel PART 08: Geographical segmentation • Tobacco alternative gums market in Americas • Tobacco alternative gums market in Europe • Tobacco alternative gums market in APAC • Tobacco alternative gums market in MEA PART 09: Key leading countries • US • Germany • France • China PART 10: Market drivers PART 11: Impact of drivers PART 12: Market challenges PART 13: Impact of drivers and challenges PART 14: Market trends PART 15: Vendor landscape • Competitive scenario • GlaxoSmithKline • Johnson & Johnson • Novartis • Reynolds American Incorporated • Other prominent vendors PART 16: Appendix • List of abbreviations List of Exhibits Exhibit 01: Percentage of people smoking in various countries 2015 Exhibit 02: Overview of global tobacco alternative gums market 2016 Exhibit 03: Global smoking cessation market 2016-2021 ($ billions) Exhibit 04: Global tobacco alternative gums market 2016-2021 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Global tobacco alternative gums market by nicotine content 2016 and 2021 Exhibit 07: Global 2-mg nicotine gum market 2016-2021 ($ billions) Exhibit 08: Global 4-mg nicotine gum market 2016-2021 ($ billions) Exhibit 09: Global tobacco alternative gums market by distribution channel 2016 Exhibit 10: Global tobacco alternative gums market by geography 2016 and 2021 Exhibit 11: Tobacco alternative gums market in Americas 2016-2021 ($ billions) Exhibit 12: Tobacco alternative gums market in Europe 2016-2021 ($ billions) Exhibit 13: Tobacco alternative gums market in APAC 2016-2021 ($ billions) Exhibit 14: Tobacco alternative gums market in MEA 2016-2021 ($ billions) Exhibit 15: Key leading countries Exhibit 16: Tobacco alternative gums market in US 2016-2021 ($ billions) Exhibit 17: Tobacco alternative gums market in Germany 2016-2021 ($ billions) Exhibit 18: Tobacco alternative gums market in France 2016-2021 ($ billions) Exhibit 19: Tobacco alternative gums market in China 2016-2021 ($ billions) Exhibit 20: Impact of drivers Exhibit 21: Impact of drivers and challenges Exhibit 22: Competitive assessment of major players in global tobacco alternative gums market Exhibit 23: GlaxoSmithKline: Business segmentation by revenue 2015 ($ billions) Exhibit 24: GlaxoSmithKline: Operating profit comparison 2014 and 2015 ($ billions) Exhibit 25: GlaxoSmithKline: EBITDA comparison 2014 and 2015 ($ billions) Exhibit 26: GlaxoSmithKline in global tobacco alternative gums market Exhibit 27: Johnson & Johnson manufacturing facilities by geography Exhibit 28: Johnson & Johnson: Business segmentation by revenue 2015 ($ billions) Exhibit 29: Johnson & Johnson: Total sales comparison 2014 and 2015 ($ billions) Exhibit 30: Johnson & Johnson: EBITDA comparison 2014 and 2015 ($ billions) Exhibit 31: Johnson & Johnson in global tobacco alternative gums market Exhibit 32: Novartis: Business segmentation by revenue 2015 ($ billions) Exhibit 33: Novartis: Net sales comparison 2014 and 2015 ($ billions) Exhibit 34: Novartis: Net income comparison 2014 and 2015 ($ billions) Exhibit 35: Novartis in global tobacco alternative gums market Exhibit 36: Reynolds American Incorporated: Nets sales comparison 2014 and 2015 ($ billions) Exhibit 37: Reynolds American Incorporated: Operating income comparison 2014 and 2015 ($ billions) Exhibit 38: Reynolds American Incorporated: Net income comparison 2014 and 2015 ($ billions) Exhibit 39: Reynolds American Incorporated in global tobacco alternative gums market

GlaxoSmithKline, Johnson & Johnson, Novartis, Reynolds American Incorporated, Alkalon, Costco, Revolymer, Target, Walgreen, and Wal-Mart